MD Anderson Events
Ethics Seminar Series: The 'Myriad' Dilemma: Should We Be Able To Patent Our Genes?
The session will consider how healthcare professionals sometimes encounter ethical challenges in their practice. These individuals will gain insight into the current debate involving the nexus between the drive to provide innovative therapies and better patient outcomes with the incentives for health care entrepreneurship and remuneration. At the core of this intellectual property policy debate is the impact and reliance we have on technology/diagnostics as well as the fundamental question of "do we own our bodies?" This presentation will explore some of these issues and open a discussion to address them for social workers, physicians, nurses and ethicists.
Date: 6/11/13, 12pm to 1pm
Time: 6/11/13, 12pm to 1pm
Directions: Pickens Academic Tower
CME: The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit TM
Facilitator: Jessica A. Moore, DHCE
Speaker: Jeff Farroni, PhD, JD
Contact: Brittany Campbell - (713) 794-1495 - email@example.com
Ethics Seminar Announcment_ June 2013.pdf (PDF, 518 KB)
- Pancreas Cancer Seminar Series
- Training in Brain Tumor Research Seminars presents Dihua Yu, M.D., Ph.D.
- Targeting metabolism through OxPhos inhibition in leukemia
- From Burnout to Brilliance: Physician Wellness Symposium
- S2M Science to Medicine Seminar Series - "Epigenetic regulation by arginine methylation in muscle stem cells and in cancer"
- Lymphoma/Myeloma Update for Patients: What's New for 2017? In Houston
- AACR Annual Meeting 2017 - MD Anderson Alumni and Faculty Association Reception
- Targeted & Immunotherapy: The New Era in Cancer Management
- Training in Brain Tumor Research Seminars presents Sina Safayi, D.V.M., Ph.D.
- Department of Molecular & Cellular Oncology Seminar